Literature DB >> 20133706

COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis.

Jun Qin1, Xinpu Chen, Xin Xie, Ming-Jer Tsai, Sophia Y Tsai.   

Abstract

Tumor growth depends on nutrients and oxygen supplied by the vasculature through angiogenesis. Here, we show that the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), a member of the nuclear receptor family, is a major angiogenesis regulator within the tumor microenvironment. Conditional ablation of COUP-TFII in adults severely compromised neoangiogenesis and suppressed tumor growth in xenograft mouse models. In addition, tumor growth and tumor metastasis were also impaired in a spontaneous mammary-gland tumor model in the absence of COUP-TFII. We showed that COUP-TFII directly regulates the transcription of Angiopoietin-1 in pericytes to enhance neoangiogenesis. Importantly, provision of Angiopoietin-1 partially restores the angiogenic defects exhibited by the COUP-TFII-deficient mice, which supports the notion that COUP-TFII controls Angiopoietin-1/Tie2 signaling to regulate tumor angiogenesis. Because COUP-TFII has little impact on normal adult physiological function, our results raise an interesting possibility that inhibition of COUP-TFII may offer a therapeutic approach for anticancer intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133706      PMCID: PMC2840495          DOI: 10.1073/pnas.0914619107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Vascular-specific growth factors and blood vessel formation.

Authors:  G D Yancopoulos; S Davis; N W Gale; J S Rudge; S J Wiegand; J Holash
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

2.  Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

Authors:  Akiyoshi Uemura; Minetaro Ogawa; Masanori Hirashima; Takashi Fujiwara; Shinji Koyama; Hitoshi Takagi; Yoshihito Honda; Stanley J Wiegand; George D Yancopoulos; Shin-Ichi Nishikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Authors:  Nicholas W Gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

4.  Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.

Authors:  J Larsson; M J Goumans; L J Sjöstrand; M A van Rooijen; D Ward; P Levéen; X Xu; P ten Dijke; C L Mummery; S Karlsson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

5.  Angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice.

Authors:  Winston S N Shim; Ming Teh; Akanksha Bapna; Injune Kim; Gou-Young Koh; Peter O P Mack; Ruowen Ge
Journal:  Exp Cell Res       Date:  2002-10-01       Impact factor: 3.905

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

7.  Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall.

Authors:  Per Lindblom; Holger Gerhardt; Stefan Liebner; Alexandra Abramsson; Maria Enge; Mats Hellstrom; Gudrun Backstrom; Simon Fredriksson; Ulf Landegren; Henrik C Nystrom; Goran Bergstrom; Elisabetta Dejana; Arne Ostman; Per Lindahl; Christer Betsholtz
Journal:  Genes Dev       Date:  2003-08-01       Impact factor: 11.361

8.  Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.

Authors:  Oliver Stoeltzing; Syed A Ahmad; Wenbiao Liu; Marya F McCarty; Jane S Wey; Alexander A Parikh; Fan Fan; Niels Reinmuth; Michiya Kawaguchi; Corazon D Bucana; Lee M Ellis
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 10.  Renal effects of anti-angiogenesis therapy: update for the internist.

Authors:  Faina Gurevich; Mark A Perazella
Journal:  Am J Med       Date:  2009-04       Impact factor: 4.965

View more
  56 in total

1.  COUP-TFII is essential for metanephric mesenchyme formation and kidney precursor cell survival.

Authors:  Cheng-Tai Yu; Ke Tang; Jae Mi Suh; Rulang Jiang; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Development       Date:  2012-07       Impact factor: 6.868

2.  Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma.

Authors:  Changjun He; Xue-Pu Sun; Haiquan Qiao; Xian Jiang; Dongdong Wang; Xiangguo Jin; Xuesong Dong; Jizhou Wang; Hongchi Jiang; Xueying Sun
Journal:  Cancer Sci       Date:  2012-01-13       Impact factor: 6.716

3.  Chicken ovalbumin upstream promoter transcription factor II regulates renin gene expression.

Authors:  Sandra Mayer; Marc Roeser; Peter Lachmann; Sumiyashi Ishii; Jae Mi Suh; Sabine Harlander; Michael Desch; Coy Brunssen; Henning Morawietz; Sophia Y Tsai; Ming-Jer Tsai; Bernd Hohenstein; Christian Hugo; Vladimir T Todorov
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

4.  Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.

Authors:  Jun Qin; Xinpu Chen; Li-Yuan Yu-Lee; Ming-Jer Tsai; Sophia Y Tsai
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

5.  Orphan nuclear receptor COUP-TFII is an oncogenic gene in renal cell carcinoma.

Authors:  X Fang; C-X Liu; X-R Zeng; X-M Huang; W-L Chen; Y Wang; F Ai
Journal:  Clin Transl Oncol       Date:  2019-07-31       Impact factor: 3.405

6.  20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.

Authors:  Li Chen; Rachel Ackerman; Mohamed Saleh; Katherine H Gotlinger; Michael Kessler; Lawrence G Mendelowitz; John R Falck; Ali S Arbab; A Guillermo Scicli; Michal L Schwartzman; Jing Yang; Austin M Guo
Journal:  J Pharmacol Exp Ther       Date:  2014-01-08       Impact factor: 4.030

7.  COUP-TFII, a prognostic marker and therapeutic target for prostate cancer.

Authors:  Jun Qin; Sophia Tsai; Ming-Jer Tsai
Journal:  Asian J Androl       Date:  2013-02-25       Impact factor: 3.285

8.  COUP-TFII is a major regulator of cell cycle and Notch signaling pathways.

Authors:  Xinpu Chen; Jun Qin; Chiang-Min Cheng; Ming-Jer Tsai; Sophia Y Tsai
Journal:  Mol Endocrinol       Date:  2012-06-25

Review 9.  Choose your destiny: Make a cell fate decision with COUP-TFII.

Authors:  San-Pin Wu; Cheng-Tai Yu; Sophia Y Tsai; Ming-Jer Tsai
Journal:  J Steroid Biochem Mol Biol       Date:  2015-12-02       Impact factor: 4.292

Review 10.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.